ChemoCentryx

CCXI

CCXI
ChemoCentryx Stock Quote
$62.02 -$1.37 -2.2%
Price as of January 15, 2021, 9:00 p.m. EST View Interactive CCXI Charts

Chemocentryx Inc. is a biopharmaceutical company focused on discovering developing and commercializing orally-administered therapeutics to treat autoimmune diseases inflammatory disorders and cancer.

Interactive Chart


News & Analysis: ChemoCentryx

All

Market Moves

Earnings









Is This Small-Cap Biotech a Buy Before 2020?

Stocks of drug developers, particularly small ones, can skyrocket or crater based on late-stage clinical trials. Before year-end, ChemoCentryx may do one or the other.